Charles Schwab Investment Management Inc Allakos Inc. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Allakos Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 181,731 shares of ALLK stock, worth $181,731. This represents 0.0% of its overall portfolio holdings.

Number of Shares
181,731
Previous 181,731 -0.0%
Holding current value
$181,731
Previous $496,000 54.03%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
BUY
$3.6 - $5.25 $547,110 - $797,868
151,975 Added 510.74%
181,731 $792,000
Q4 2022

Feb 13, 2023
SELL
$5.97 - $8.42 $42,088 - $59,361
-7,050 Reduced 19.15%
29,756 $250,000
Q3 2022

Nov 14, 2022
SELL
$3.02 - $5.84 $358,431 - $693,126
-118,686 Reduced 76.33%
36,806 $226,000
Q2 2022

Aug 15, 2022
SELL
$2.6 - $6.14 $217,331 - $513,236
-83,589 Reduced 34.96%
155,492 $487,000
Q1 2022

May 13, 2022
SELL
$5.08 - $9.81 $53,467 - $103,250
-10,525 Reduced 4.22%
239,081 $1.36 Million
Q4 2021

Feb 11, 2022
BUY
$8.55 - $111.89 $49,897 - $652,990
5,836 Added 2.39%
249,606 $2.44 Million
Q3 2021

Nov 16, 2021
BUY
$76.53 - $110.43 $302,446 - $436,419
3,952 Added 1.65%
243,770 $25.8 Million
Q2 2021

Aug 16, 2021
BUY
$85.37 - $114.1 $2.02 Million - $2.7 Million
23,631 Added 10.93%
239,818 $20.5 Million
Q1 2021

May 17, 2021
BUY
$109.73 - $153.66 $849,310 - $1.19 Million
7,740 Added 3.71%
216,187 $24.8 Million
Q4 2020

Feb 16, 2021
BUY
$79.58 - $152.45 $1.9 Million - $3.63 Million
23,825 Added 12.9%
208,447 $29.2 Million
Q3 2020

Nov 13, 2020
BUY
$66.43 - $90.99 $907,234 - $1.24 Million
13,657 Added 7.99%
184,622 $15 Million
Q2 2020

Aug 14, 2020
BUY
$44.04 - $80.69 $893,307 - $1.64 Million
20,284 Added 13.46%
170,965 $12.3 Million
Q1 2020

May 15, 2020
BUY
$44.49 - $93.39 $500,512 - $1.05 Million
11,250 Added 8.07%
150,681 $6.7 Million
Q4 2019

Feb 07, 2020
BUY
$66.49 - $137.73 $262,834 - $544,446
3,953 Added 2.92%
139,431 $13.3 Million
Q3 2019

Nov 08, 2019
BUY
$31.0 - $89.73 $2.16 Million - $6.26 Million
69,725 Added 106.04%
135,478 $10.7 Million
Q2 2019

Aug 09, 2019
BUY
$36.0 - $44.73 $353,700 - $439,472
9,825 Added 17.57%
65,753 $2.85 Million
Q1 2019

May 14, 2019
BUY
$33.79 - $51.99 $435,992 - $670,826
12,903 Added 29.99%
55,928 $2.27 Million
Q4 2018

Feb 14, 2019
BUY
$31.59 - $62.65 $43,246 - $85,767
1,369 Added 3.29%
43,025 $2.25 Million
Q3 2018

Nov 13, 2018
BUY
$31.25 - $47.64 $1.3 Million - $1.98 Million
41,656 New
41,656 $1.88 Million

Others Institutions Holding ALLK

# of Institutions
104
Shares Held
77.4M
Call Options Held
70.7K
Put Options Held
2.8K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $84.7M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email